Morgan Stanley’s MicroSectors FANG+ ETNs due Jan 8 2038 FNGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.26K Sell
100
-249
-71% -$17.9K ﹤0.01% 7133
2026
Q1
$20.8K Sell
349
-4,467
-93% -$285K ﹤0.01% 6713
2025
Q4
$328K Buy
4,816
+2,014
+72% +$142K ﹤0.01% 5722
2025
Q3
$196K Sell
2,802
-2,619
-48% -$175K ﹤0.01% 5901
2025
Q2
$353K Buy
5,421
+3,808
+236% +$215K ﹤0.01% 5623
2025
Q1
$80.4K Sell
1,613
-91
-5% -$5.12K ﹤0.01% 6110
2024
Q4
$97.7K Buy
1,704
+185
+12% +$9.95K ﹤0.01% 6069
2024
Q3
$75.1K Buy
+1,519
New +$73.6K ﹤0.01% 6102
2024
Q1
Sell
-65
Closed -$2.45K 7879
2023
Q4
$2.45K Buy
+65
New +$2.25K ﹤0.01% 7009
2022
Q3
Sell
-800
Closed -$17K 7756
2022
Q2
$17K Buy
800
+775
+3,100% +$18.1K ﹤0.01% 7043
2022
Q1
$1K Buy
+25
New +$717 ﹤0.01% 7840

Other funds holding FNGS

Morgan Stanley's FNGS Position: Q2 2026 in Review

Morgan Stanley reduced its MicroSectors FANG+ ETNs due Jan 8 2038 (FNGS) stake by 71% in Q2 2026, selling an estimated $17.9K and leaving 100 shares worth $7.26K. The position accounts for ﹤0.01% of the portfolio, ranked #7133.

Morgan Stanley first reported a position in FNGS in Q1 2022 and has held it in 11 quarters since. The position peaked at $353K in Q2 2025. 38 funds tracked by Wall St. Rank hold FNGS as of Q2 2026.

  • Morgan Stanley held 100 shares of MicroSectors FANG+ ETNs due Jan 8 2038 worth $7.26K as of Q2 2026.
  • Morgan Stanley sold 249 MicroSectors FANG+ ETNs due Jan 8 2038 shares in Q2 2026, an estimated $17.9K.
  • MicroSectors FANG+ ETNs due Jan 8 2038 made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7133 holding.
  • Morgan Stanley first reported a position in MicroSectors FANG+ ETNs due Jan 8 2038 in Q1 2022 and has held it in 11 quarters since.
  • Morgan Stanley's MicroSectors FANG+ ETNs due Jan 8 2038 position peaked at $353K in Q2 2025.
  • 38 funds tracked by Wall St. Rank held MicroSectors FANG+ ETNs due Jan 8 2038 as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.